RUCAPARIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where RUCAPARIB was used for Neoplasm malignant.
Most Reported Side Effects for RUCAPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Anaemia | 49 | 11.3% | 2 | 37 |
| Acute kidney injury | 34 | 7.8% | 6 | 34 |
| Febrile neutropenia | 33 | 7.6% | 2 | 33 |
| Fatigue | 32 | 7.4% | 1 | 10 |
| Nausea | 30 | 6.9% | 0 | 15 |
| Pancytopenia | 27 | 6.2% | 2 | 24 |
| Diarrhoea | 23 | 5.3% | 1 | 18 |
| Drug ineffective | 22 | 5.1% | 6 | 1 |
| Vomiting | 20 | 4.6% | 0 | 16 |
| Abdominal pain | 17 | 3.9% | 0 | 15 |
| Thrombocytopenia | 17 | 3.9% | 4 | 12 |
| Constipation | 15 | 3.5% | 0 | 5 |
| Malignant neoplasm progression | 15 | 3.5% | 8 | 6 |
| Pyrexia | 13 | 3.0% | 0 | 11 |
| Decreased appetite | 12 | 2.8% | 0 | 3 |
Other Indications for RUCAPARIB
Ovarian cancer (201)
Prostate cancer metastatic (34)
Small cell lung cancer (29)
Hormone-refractory prostate cancer (27)
Prostate cancer (27)
Endometrial cancer (15)
Neoplasm (13)
Product used for unknown indication (12)
Fallopian tube cancer (9)
Malignant peritoneal neoplasm (7)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)